The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.EBI
University of Toronto
Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.EBI
The University of Sydney
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors.EBI
University of Messina
Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.EBI
University of Messina
Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.EBI
University of Mississippi
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.EBI
University of Messina
Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.EBI
University of Mississippi
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain.EBI
University of Messina
Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.EBI
University of Algarve
A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.EBI
International Center For Genetic Engineering and Biotechnology
Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.EBI
Université
New structural classes of antimalarials.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of EBI
Jamia Millia Islamia (A Central University)
Is structural hybridization invoking new dimensions for antimalarial drug discovery research?EBI
University of Delhi
Falcipains: Biochemistry, target validation and structure-activity relationship studies of inhibitors as antimalarials.EBI
University of Petroleum and Energy Studies
Dipeptide vinyl sultams: synthesis via the Wittig-Horner reaction and activity against papain, falcipain-2 and Plasmodium falciparum.EBI
University of Lisbon
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain.EBI
University of California San Francisco
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.EBI
University of California San Francisco
Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.EBI
University of Cape Town
Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.EBI
Shoolini University of Biotechnology and Management Sciences
Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.EBI
Wuxi Apptec
Falcipain Inhibitors Based on the Natural Product Gallinamide A Are Potent in Vitro and in Vivo Antimalarials.EBI
The University of Sydney
Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.EBI
Universidad Central De Venezuela
New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8.EBI
Johannes Gutenberg-Universit£T Mainz
Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.EBI
Irbm Science Park
Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.EBI
Delhi Institute of Pharmaceutical Sciences and Research
Quinoline hybrids and their antiplasmodial and antimalarial activities.EBI
Hubei Engineering University
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).EBI
University of Messina
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavir.BDB
Merck Research Laboratories